Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) EPS (Weighted Average and Diluted) (2018 - 2025)

Historic EPS (Weighted Average and Diluted) for Organogenesis Holdings (ORGO) over the last 8 years, with Q3 2025 value amounting to $0.11.

  • Organogenesis Holdings' EPS (Weighted Average and Diluted) rose 2222.22% to $0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.12, marking a year-over-year decrease of 10000.0%. This contributed to the annual value of -$0.01 for FY2024, which is 11779.02% down from last year.
  • According to the latest figures from Q3 2025, Organogenesis Holdings' EPS (Weighted Average and Diluted) is $0.11, which was up 2222.22% from -$0.09 recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' EPS (Weighted Average and Diluted) ranged from a high of $0.38 in Q4 2021 and a low of -$0.17 during Q1 2025
  • Over the past 5 years, Organogenesis Holdings' median EPS (Weighted Average and Diluted) value was $0.04 (recorded in 2023), while the average stood at $0.04.
  • Per our database at Business Quant, Organogenesis Holdings' EPS (Weighted Average and Diluted) surged by 114276.32% in 2024 and then tumbled by 75000.0% in 2025.
  • Over the past 5 years, Organogenesis Holdings' EPS (Weighted Average and Diluted) (Quarter) stood at $0.38 in 2021, then plummeted by 84.21% to $0.06 in 2022, then tumbled by 107.13% to -$0.0 in 2023, then skyrocketed by 1142.76% to $0.04 in 2024, then soared by 146.54% to $0.11 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.11 in Q3 2025, compared to -$0.09 in Q2 2025 and -$0.17 in Q1 2025.